P349-1029 Screening compound: 1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-3-({2-phenylimidazo[1,2-a]pyrazin-3-yl}amino)propan-1-one

P349-1029 Screening compound: 1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-3-({2-phenylimidazo[1,2-a]pyrazin-3-yl}amino)propan-1-one
P349-1029 Screening compound: 1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-3-({2-phenylimidazo[1,2-a]pyrazin-3-yl}amino)propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound P349-1029
1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-3-({2-phenylimidazo[1,2-a]pyrazin-3-yl}amino)propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P349-1029

Molecular Formula

C25H33N7O (C25 H33 N7 O)

Compound Name

1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-3-({2-phenylimidazo[1,2-a]pyrazin-3-yl}amino)propan-1-one

IUPAC name

1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-3-({2-phenylimidazo[12-a]pyrazin-3-yl}amino)propan-1-one

SMILES

CN(CC1)CCC1N(CC1)CCN1C(CCNc1c(-c2ccccc2)nc2n1ccnc2)=O

InChI

InChI=1S/C25H33N7O/c1-29-12-8-21(9-13-29)30-15-17-31(18-16-30)23(33)7-10-27-25-24(20-5-3-2-4-6-20)28-22-19-26-11-14-32(22)25/h2-6,11,14,19,21,27H,7-10,12-13,15-18H2,1H3

InChI Key

VWDDTOAAQRBPSI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27573362

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.58

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.135

Distribution Coefficient, logD

-0.480

Water Solubility, LogSw

-1.35

Polar Surface Area

51.323

Acid Dissociation Constant (pKa)

20.43

Base Dissociation Constant (pKb)

9.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.00

P349-1029 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with P349-1029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P349-1029?
Check Price and Availability of P349-1029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P349-1029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P349-1029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P349-1029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P349-1029 available by request